Last reviewed · How we verify
Autologous BMDC implantation at the venous ulcer — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Autologous BMDC implantation at the venous ulcer (Autologous BMDC implantation at the venous ulcer) — Hospital de Clínicas Dr. Manuel Quintela.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Autologous BMDC implantation at the venous ulcer TARGET | Autologous BMDC implantation at the venous ulcer | Hospital de Clínicas Dr. Manuel Quintela | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Autologous BMDC implantation at the venous ulcer CI watch — RSS
- Autologous BMDC implantation at the venous ulcer CI watch — Atom
- Autologous BMDC implantation at the venous ulcer CI watch — JSON
- Autologous BMDC implantation at the venous ulcer alone — RSS
Cite this brief
Drug Landscape (2026). Autologous BMDC implantation at the venous ulcer — Competitive Intelligence Brief. https://druglandscape.com/ci/autologous-bmdc-implantation-at-the-venous-ulcer. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab